¶ Novavax
.png)
Novavax is an American biotechnology company based in Gaithersburg, Maryland.
¶ History
Novavax sponsored the OPTIONS IX for the Control of Influenza conference from August 24-28, 2016 in Chicago, Illinois.[1]
¶ COVID-19
On April 13, 2020, the World Health Organization (WHO) published a "Public statement for collaboration on COVID-19 vaccine development." Gale Smith, Novavax's Chief Scientist, was a signatory.[2]
Novavax is a participating organization in the Accelerating COVID-19 Therapeutic Interventions and Vaccines initiative, first announced April 17, 2020.[3]
Novavax received up to $399 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of its COVID-19 vaccine candidate.[4]
Representatives of Novavax met with the Government of Canada's COVID-19 Vaccine Task Force on July 23 and December 10, 2020 to discuss its COVID-19 vaccine candidate.[5]
On February 2, 2021, Innovation, Science and Economic Development Canada signed a memorandum of understanding with Novavax to produce its COVID-19 vaccine candidate at National Research Council Canada's Biologics Manufacturing Centre.[6]
COVAX reached a supply agreement with Novavax for its Nuvaxovid product, as well as for Covovax, which the company co-developed with the Serum Institute of India (SII).[7] Novavax CEO Stanley Erck attended the One World Protected event hosted by Gavi, the Vaccine Alliance on April 15, 2021, during which COVAX was officially launched.[8]
On February 17, 2022, Health Canada authorized the Novavax COVID-19 vaccine for use in adults.[9]
Novavax sponsored the World Vaccine Congress Washington 2022, which took place from April 18-21, 2022.[10]
On July 13, 2022, the Food and Drug Administration granted an Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine.[11]
¶ Organization
Novavax is a member or partner of:
- Adult Vaccine Access Coalition (AVAC)[12]
- Biotechnology Innovation Organization (BIO)[13]
- European Federation of Pharmaceutical Industries and Associations (EFPIA)[14]
- Medical CBRN Defense Consortium[15]
- National Foundation for Infectious Diseases (NFID)[16]
Novavax has provided notable funding to:
- IDSA Foundation[17]
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Stanley Erck | CEO[8:1] | - |
| Gale Smith | Senior Vice President of Discovery and Pre-clinical Research, Chief Scientist[18] | Protein Sciences |
| John Spears | CEO (former)[19] | Intradigm[20] |
¶ External links
OPTIONS IX Supporters. OPTIONS IX. Retrieved July 7, 2017, from https://web.archive.org/web/20170707010655/http://2016.isirv.org/options-ix-supporters ↩︎
Jasarevic, T. (2020, April 16). Public statement for collaboration on COVID-19 vaccine development. World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development ↩︎
ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎
Our portfolio. CEPI. Retrieved October 21, 2022, from https://web.archive.org/web/20221021070613/https://cepi.net/research_dev/our-portfolio/ ↩︎
COVID-19 Vaccine Task Force Registry of Interests. (2023, March 27). Innovation, Science and Economic Development Canada. http://archive.today/2023.07.09-180656/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-vaccine-task-force-registry-interests ↩︎
Backgrounder – Government of Canada investments in COVID-19 vaccines, therapeutics and biomanufacturing capacity. (2021, February 2). Innovation, Science and Economic Development Canada. http://archive.today/2021.02.17-210959/https://www.canada.ca/en/innovation-science-economic-development/news/2021/02/backgrounder--government-of-canada-investments-in-covid-19-vaccines-and-biomanufacturing-capacity.html ↩︎
Gavi COVAX AMC 2021 Investment Opportunity Launch Event. (2022, January 29). Gavi, the Vaccine Alliance. https://web.archive.org/web/20220820112357/https://www.gavi.org/gavi-covax-amc-launch-event-april-2021 ↩︎
The Gavi COVAX AMC Investment Opportunity Launch Event Participant List. (2021). Gavi, the Vaccine Alliance; USAID; U.S. Department of State. https://web.archive.org/web/20220821050428/https://www.gavi.org/sites/default/files/covid/covax/Investment-Opportunity-Launch-Participant-List.pdf ↩︎ ↩︎
Parkhill, M. (2022, February 17). Novavax vaccine authorized for use in Canada. CTV News. http://archive.today/2022.02.17-170358/https://www.ctvnews.ca/health/coronavirus/novavax-vaccine-authorized-for-use-in-canada-1.5785244 ↩︎
Sponsors & exhibitors | Vaccine Congress USA. (2022, April 21). World Vaccine Congress Washington 2022. http://archive.today/2022.04.22-012231/https://www.terrapinn.com/conference/world-vaccine-congress-washington/sponsors-and-exhibitors.stm ↩︎
Capobianco, A. (2022, July 13). Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted. Food and Drug Administration. https://web.archive.org/web/20220713201410/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted ↩︎
AVAC Member Organizations. (2021). Adult Vaccine Access Coalition. http://archive.today/2022.07.08-060340/https://adultvaccinesnow.org/our-membership/avac-member-organizations/ ↩︎
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎
Membership. (2022). European Federation of Pharmaceutical Industries and Association. https://web.archive.org/web/20220701031757/https://www.efpia.eu/about-us/membership/ ↩︎
Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎
Strategic Partners. National Foundation for Infectious Diseases. Retrieved July 16, 2022, from http://archive.today/2022.07.16-073224/https://www.nfid.org/about-nfid/strategic-partners/ ↩︎
Home. IDSA Foundation. Retrieved October 8, 2022, from https://web.archive.org/web/20221008025156/https://idsafoundation.org/ ↩︎
Meet Gale E. Smith, PhD. Novavax. Retrieved April 17, 2023, from https://web.archive.org/web/20230417112829/https://www.novavax.com/who-we-are/leadership/gale-e-smith-phd ↩︎
Ex-chief of Novavax hired as Intradigm CEO. (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1 ↩︎
Intradigm appoints John A. Spears Chairman and CEO. (2002, December 2). PharmaBiz. http://archive.today/2023.03.04-202058/http://test.pharmabiz.com/news/intradigm-appoints-john-a-spears-chairman-and-ceo-12922 ↩︎